Senior Public Affairs Advisor
HOLLAND & KNIGHT’S WASHINGTON, D.C.
Miranda Franco is a senior public affairs advisor in Holland & Knight’s Washington, D.C., office and a member of the firm’s Public Policy & Regulation Group. She has more than a decade of collective experience in health policy and government relations, representing advocacy positions to policymakers, national physician specialty societies, state medical societies, hospitals and other healthcare organizations. Ms. Franco has designed and promoted a variety of legislative and regulatory remedies on behalf of hospital, hospital system, life science, patient and provider groups. She has the ability to translate complex legal and regulatory issues into a practical, real-world framework to help her clients find solutions to healthcare’s most challenging problems. Ms. Franco has extensive knowledge of Medicare’s physician and hospital reimbursement process, Medicare’s quality improvement initiatives, advancements in health information technology, Accountable Care Organizations and other innovative payment models, health system reform, public health preparedness programs, implementation of the Medicare Access and CHIP Reauthorization Act (MACRA), and other health-related issues. She routinely advises on coding, coverage and reimbursement for both providers and life science companies, and builds coalitions that advance the healthcare priorities of her clients. Prior to joining Holland & Knight, Ms. Franco served as the government affairs representative for the Medical Group Management Association (MGMA), where she led the association’s advocacy efforts to help medical group practices meet the challenges posed by a rapidly evolving healthcare marketplace. Prior to joining the MGMA, Ms. Franco worked for the American Society of Plastic Surgeons, lobbying members of Congress on federal healthcare issues, in particular Medicare reimbursement.
Miranda will be one of the distinguished speakers at the Healthcare Financial Forum.
Why is the Healthcare Financial Forum important for finance executives?
Six years after the biggest overhaul of U.S. health care in half a century, the healthcare industry is bracing yet again for more change. There are a lot of policy questions and moving parts to follow. However, there is no question that the healthcare landscape will significantly change over the coming years. These changes create an extremely complex landscape that presents as many opportunities as it does challenges. As health care access, delivery, technology and reimbursement experience massive transformation, it is important and timely to remain focused on how to thrive in this rapidly evolving industry. Change is coming, but that change, necessary to both develop a new system as well as transition from the old, will take time. Engaging in discussions now with policy makers and stakeholders is key to being a part of the dialogue and informing the final product.